Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSMarket Beat·2 hours agoCOCH+2.80%
Envoy Medical, Inc. Q2 2026: Revenue $51K, Net loss $5982K — 10-Q SummaryTradingView·2 hours agoCOCH+2.80%
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones | COCH Stock NewsStockTitan·10 hours agoCOCH+2.80%
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky IndustrialMorningStar·Aug 1 at 10:38 AMDVLT-2.73%BSIN-0.41%
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)MorningStar·Jul 18 at 12:03 PMBSIN-0.41%COCH+2.80%
EXCLUSIVE: Envoy Medical Builds Momentum With Improved Cochlear Implant Trial Resultsbenzinga_article·Jul 14 at 08:01 AMCOCH+2.80%
Envoy Medical Reports Positive 12-Month Data Showing Continued Improvement in Speech Perception in Study of First-of-Its-Kind Fully Implanted Cochlear Implant | COCH Stock NewsStockTitan·Jul 14 at 12:17 AMCOCH+2.80%
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device | COCH Stock NewsStockTitan·Jun 29 at 11:30 PMCOCH+2.80%
